@khalahleh1 Profile picture

khalid A. Halahleh

@khalahleh1

Khalid Halahleh MD, Head of Adult BMT&CT Program @KHCC Medical Oncologist Hematologist &Bone Marrow Transplantation and Cellular Therapy

Similar User
AAACTT photo

@AAACTT_org

Mohamed Kharfan-Dabaja, MD, MBA photo

@MKD_BMT

Muna Qayed photo

@MunaQayed

Monzr M. AlMalki, MD photo

@DrMonzrAlMalki

Nora Chokr photo

@NChokr

Mostafa Faisal photo

@MostafaFaisal14

Razan Mohty photo

@Razan_Mohty

Mohammad Ali photo

@MohammadOAli91

Carmem Bonfim photo

@CarmemBonfim1

Amer Beitinjaneh, MD, MSc, MPH, FACP photo

@abeitin

A Samer Al-Homsi photo

@ASamerAlHomsi1

Naveed Ali photo

@drnaveedalimd

Betty Ky Hamilton photo

@hamiltkyb

Ayman Saad photo

@aymansaadOSU

Joe Maakaron photo

@jmaakaron

A good piece of information on CNS orevention prior to alloSct Prophylactic Cranial Irradiation prior to HCT for Acute Lymphoblastic Leukemia: To Boost or Not To Boost. pubmed.ncbi.nlm.nih.gov/39417015/


khalid A. Halahleh Reposted

Food decided to stop going into Gaza @CNN ? Thanks for the very informative typical title..

No food has entered northern Gaza since the start of October, putting 1 million people at risk of going hungry, the World Food Programme says cnn.it/4eGUqww



Dr. Ramzi aboud presenting managment of GvHD in 2024 @AAACTG in colaboration wigh @KHFKHCC

Tweet Image 1

Cession on GvHD prophylaxis in 2025 Day#2 continued @AAACTT in colaboration with @KHFKHCC

Tweet Image 1

Day#2 @AAACTT in colaborqrtion with @KHFKHCC Dr. Almalki Monzer presenting GvHD prophylaxis in 2024

Tweet Image 1

@khalahleh1 Dr. Hisham Abdel-Azim prestning on CART cell symposium @AAACTG in collaborqtion wigj @KHFKHC

Tweet Image 1

Dr. Rawad Rihani presenting on transplant for Begnin conditions @AAACTT_org in collaboration with @KHFKHCC

Tweet Image 1

The First Annual Conference of @AAACTT in collaboration with @KHCFKHCC

Tweet Image 1

khalid A. Halahleh Reposted

Looking forward to 1st ⁦@AAACTT_org⁩ scientific conference in collaboration with ⁦@KHCFKHCC

Tweet Image 1

khalid A. Halahleh Reposted

#EHA2024 If PFS is similar in MRD negative patients at 10-6 regardless of treatment, it could become important to predict upfront whose patients can achieve MRD negativity with one regimen or other for individualized sequential treatment approaches #mmsm

Tweet Image 1

Asciminib Shows Superiority Over Available Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia dailynews.ascopubs.org/do/asciminib-s…


khalid A. Halahleh Reposted

Ponatinib induces high cytogenetic and molecular responses in frontline CML-CP. However, adverse events hinder its use in the frontline setting: @FadiHaddad_MD @MDAndersonNews #Leukemia acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @JournalCancer #leusm #CML

Tweet Image 1
Tweet Image 2

khalid A. Halahleh Reposted

AAACTT is cordially inviting you to join us in Amman! Our first conference is coming up in July! Exciting topics from experts in the field. Check program highlights below. #bmtsm

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

khalid A. Halahleh Reposted

New IMS high risk definition for multiple myeloma presented by Prof Corre @COMyCongress . Fantastic effort by co-operative groups to redefine risk. Clearly an evolving area.

Tweet Image 1

khalid A. Halahleh Reposted

NGS MRD (clonoSEQ) is the most sensitive and specific MRD assay in Ph+ #ALL. Therapeutic decision-making should be based on NGS rather than PCR for BCR::ABL1 @NicholasShortMD of @MDAndersonNews #Leukemia doi.org/10.1080/174740… #leusm


RCT of HCt vs No-HCT in older patieny >65 yr <75yr with FluTBI 2Gy Impressive results on long term LFS and RI at 5 yeats but small number of patients and high drop off rate

Tweet Image 1
Tweet Image 2

khalid A. Halahleh Reposted

We are delighted to announce that the previously postponed first annual @AAACTT conference will now be held on July 19-20 in Amman, Jordan. More details to follow. #bmtsm #celltherapy

Tweet Image 1

khalid A. Halahleh Reposted

Timely release at the start of #Tandem24 - Long term results of our randomized trial comparing ATG and PTCy. The case is not closed! And many important questions are still yet to be investigated. @TheIACH @TheEBMT @CIBMTR @BMTCTN @FaculteSanteSU @APHP pubmed.ncbi.nlm.nih.gov/38374026/


Great comparison

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.